NYSE:ABBV

Abbvie Stock Insider Trading

Healthcare > Drug Manufacturers - General

Buy ABBV

*Your capital is at risk

$217.07

+1.64 (+0.761%)

At Close: Jun 03, 2026

AbbVie Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -31.34. In total, the insiders bought 778.69K and sold 29.8M ABBV shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-31.34
● Buy	778.69K shares
● Sell	29.8M shares
79% Buy Activity Weak Negative Correlation
Buy Signal Low Confidence Feb 18, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -31.34. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (79% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
May 08, 2026 Buy	Common Stock, $0.01 par value A-Award	Davis Jennifer L. Director	Director	1 118 Value: $225.3K
May 08, 2026 Buy	Common Stock, $0.01 par value A-Award	Freyman Thomas C Director	Director	1 118 Value: $225.3K
May 08, 2026 Buy	Common Stock, $0.01 par value A-Award	Hart Brett J Director	Director	1 118 Value: $225.3K
May 08, 2026 Buy	Common Stock, $0.01 par value A-Award	Roberts Rebecca B Director	Director	1 118 Value: $225.3K
May 08, 2026 Buy	Common Stock, $0.01 par value A-Award	Waddell Frederick H Director	Director	1 118 Value: $225.3K
May 08, 2026 Buy	Common Stock, $0.01 par value A-Award	Falk Thomas J Director	Director	1 118 Value: $225.3K
May 08, 2026 Buy	Common Stock, $0.01 par value A-Award	Rapp Edward J Director	Director	1 118 Value: $225.3K
May 08, 2026 Buy	Common Stock, $0.01 par value A-Award	Quaggin Susan E Director	Director	1 118 Value: $225.3K
May 08, 2026 Buy	Common Stock, $0.01 par value A-Award	Meyer Melody B Director	Director	1 118 Value: $225.3K
May 08, 2026 Buy	Common Stock, $0.01 par value A-Award	Burnside William H.l. Director	Director	1 118 Value: $225.3K
May 08, 2026 Buy	Common Stock, $0.01 par value A-Award	Austin Roxanne S Director	Director	1 118 Value: $225.3K
Mar 31, 2026 Buy	Stock Equivalent Units A-Award	Quaggin Susan E Director	Director	71 Value: $15.4K
Mar 31, 2026 Buy	Stock Equivalent Units A-Award	Rapp Edward J Director	Director	155 Value: $33.7K
Mar 31, 2026 Buy	Stock Equivalent Units A-Award	Alpern Robert J Director	Director	35 Value: $8K
Mar 04, 2026 Sell	Common Stock, $0.01 par value S-Sale	Purdue David Ryan SVP, Controller	Officer	5 230 Value: $1.22M
Mar 02, 2026 Sell	Common Stock, $0.01 par value S-Sale	Siatis Perry C EVP, GC And Secretary	Officer	10 291 Value: $2.41M
Mar 02, 2026 Sell	Common Stock, $0.01 par value S-Sale	Siatis Perry C EVP, GC And Secretary	Officer	5 777 Value: $1.35M
Mar 02, 2026 Sell	Common Stock, $0.01 par value S-Sale	Siatis Perry C EVP, GC And Secretary	Officer	2 600 Value: $611.7K
Feb 27, 2026 Sell	Common Stock, $0.01 par value F-InKind	Purdue David Ryan SVP, Controller	Officer	2 108 Value: $489.2K
Feb 27, 2026 Sell	Common Stock, $0.01 par value F-InKind	Crum Demetris D EVP, Chief Hr Officer	Officer	1 594 Value: $369.9K
Feb 27, 2026 Sell	Common Stock, $0.01 par value F-InKind	Donoghoe Nicholas EVP, Chief Bus/strat Officer	Officer	12 874 Value: $2.99M
Feb 27, 2026 Sell	Common Stock, $0.01 par value F-InKind	Purdue David Ryan SVP, Controller	Officer	2 692 Value: $624.8K
Feb 27, 2026 Sell	Common Stock, $0.01 par value F-InKind	Saleki-gerhardt Azita EVP, Chief Operations Officer	Officer	16 309 Value: $3.78M
Feb 27, 2026 Sell	Common Stock, $0.01 par value F-InKind	Siatis Perry C EVP, GC And Secretary	Officer	14 850 Value: $3.45M
Feb 27, 2026 Sell	Common Stock, $0.01 par value F-InKind	Michael Robert A. Chairman Of The Board And CEO	CEO / President	36 523 Value: $8.48M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ABBVIE INC

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ...

Read Full Profile Here